绿叶制药(02186)附属完成发行150万股可交换优先股

Core Viewpoint - Luye Pharma Group has completed the issuance of 1.5 million exchangeable preferred shares, which can be exchanged for existing shares of Boan Biologics, representing approximately 16.15% of Boan Biologics' total issued shares [1] Group 1 - The issuance of exchangeable preferred shares was finalized on December 12, 2025, according to the terms of the subscription agreement [1] - The issuer, Luye Geneora Holding Limited, a wholly-owned subsidiary of Luye Pharma, allocated and issued the 1.5 million exchangeable preferred shares to the subscribers [1] - The initial exchange price is set at HKD 11.718, allowing for a maximum delivery of 100,486,431 shares of Boan Biologics upon the exchange of all preferred shares [1]